MCC
TEVA icon

Money Concepts Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Money Concepts Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,711
Closed -$24.7K – 2643
2022
Q4 		$24.7K Buy
+2,711
New +$23.7K ﹤0.01% 1569
2022
Q2 		– Sell
-2,620
Closed -$25K – 2512
2022
Q1 		$25K Buy
+2,620
New +$21.9K ﹤0.01% 1530

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Money Concepts Capital's TEVA Position: Q1 2023 in Review

Money Concepts Capital sold out of Teva Pharmaceuticals (TEVA) in Q1 2023, closing a stake of 2,711 shares — an estimated $24.7K sold.

Money Concepts Capital first reported a position in TEVA in Q1 2022 and held it in 2 quarters. The position peaked at $25K in Q1 2022. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2023.

  • Money Concepts Capital reported no remaining Teva Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 2,711 Teva Pharmaceuticals shares in Q1 2023, an estimated $24.7K.
  • Money Concepts Capital first reported a position in Teva Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Money Concepts Capital's Teva Pharmaceuticals position peaked at $25K in Q1 2022.
  • 438 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.